INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Nutex Health Inc. (NASDAQ: NUTX) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to ...

HOUSTON, July 25, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Nutex Health Inc. ("Nutex") (NASDAQ: NUTX), resulting from allegations of providing potentially misleading business information to the investing public.

If you are a Nutex investor who suffered a substantial loss and would like to learn more, you can provide your information HERE.

You can also contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 or via e-mail at elechtzin@edelson-law.com.

THE COMPANY: Nutex is a healthcare services company that develops and operates micro-hospitals and outpatient facilities. The company also manages independent physician associations through its cloud-based platform, and owns and leases healthcare real estate across the United States.

THE ALLEGED WRONGDOING: On July 22, 2025, short seller Blue Orca Capital published a report raising concerns about Nutex's relationship with HaloMD, a third-party vendor that was recently sued for allegedly engaging in a "coordinated fraudulent scheme" to defraud insurance companies on behalf of healthcare billing clients. Specifically, the report alleges that HaloMD helped Nutex generate "unsustainably high" reimbursement rates through the arbitration process outlined in the No Surprises Act (NSA), a federal law intended to protect patients from unexpected medical bills.

Following publication of the Blue Orca report, the price of Nutex stock fell $11.18 per share, or 10.05%, to close at $100.01 per share on July 22, 2025.

ABOUT EDELSON LECHTZIN LLP: Edelson Lechtzin LLP, based in suburban Philadelphia, is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class action cases alleging violations of federal antitrust laws, employee benefit plans under ERISA, wage theft, data security breaches, and consumer fraud.

For more information, please contact:

Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492 or 215-867-2399 ext. 1
Email: medelson@edelson-law.com
Email: elechtzin@edelson-law.com
Web:  www.edelson-law.com 

This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

View original content to download multimedia:https://www.prnewswire.com/news-releases/investigation-alert-edelson-lechtzin-llp-announces-an-investigation-of-nutex-health-inc-nasdaq-nutx-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-to-contact-the-firm-302514292.html

SOURCE Edelson Lechtzin LLP